MedTrace Logo

Sarpogrelate Drug Interaction

NCT02097511 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2015-02-25

No results posted yet for this study

Summary

This is a randomized, open-label, single \& multiple-dose, three-sequence, three-period crossover study to investigate the effect of sarpogrelate hydrochloride on the disposition of metoprolol tartrate in healthy male volunteers

Conditions

Interventions

DRUG

Sarpogrelate pretreatment

Sarpogrelate hydrochloride 100 mg pretreatment three times a day for three days

DRUG

Sarpogrelate

Sarpogrelate hydrochloride 100 mg three times a day

DRUG

Metoprolol

Metoprolol Tartrate 100 mg once a day

Sponsors & Collaborators

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • Doo-Yeoun Cho, MD · Ajou University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-01-31
Completion
2014-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02097511 on ClinicalTrials.gov